The generation of C5a, whose levels are highly elevated in symptomatic COVID-19 patients (in combination with a strong expression of C5aR in monocytes and neutrophils), increases tissue factor activity both in circulation57 and on endothelial cells58. This evidence concerns the gene C5AR1 and COVID-19.